Drug or treatment

Emicizumab clinical trials

• 9Clinical trials
• 31Countries

Newest trials

All recruiting trials (9)

• NXT007 versus emicizumab to prevent bleeds in people with Hemophilia A

  This will test whether NXT007 prevents bleeding better than emicizumab in people aged 12 and older with Hemophilia A, including those with or without factor VIII inhibitors.

  Recruiting at 63 sites Phase 3 Hoffmann-La Roche · Orange, California and 62 other locations · NCT07416604

• Emicizumab prophylaxis for people with Type 3 von Willebrand disease

  This trial will test whether regular emicizumab injections reduce bleeds compared with on-demand standard therapy for people aged 1 month and older with Type 3 von Willebrand disease, while also studying people already on prophylaxis using their prior data.

  Recruiting at 29 sites Phase 3 Hoffmann-La Roche · Sacramento, California and 28 other locations · NCT06998524

• Switching from Emicizumab to Marstacimab in Severe Hemophilia A

  This study is testing if switching from emicizumab to marstacimab is safe and how well the body handles the new medication in people with severe hemophilia A.

  Recruiting at 7 sites Phase 1 Pfizer · La Jolla, California and 9 other locations · NCT06703606

• Testing fitusiran to prevent bleeds in severe hemophilia A patients switching from emicizumab

  This study is testing if fitusiran can help prevent bleeding in men with severe hemophilia A who are switching from another treatment called emicizumab.

  Recruiting at 3 sites Phase 4 Sanofi · Los Angeles, California and 2 other locations · NCT06145373

• Using Nuwiq to manage bleeding in hemophilia A patients during major surgery

  This study is testing if Nuwiq can help prevent bleeding during major surgery for boys and men over 12 with severe hemophilia A who are already using another treatment called emicizumab.

  Recruiting at 17 sites Phase 4 Octapharma · Dallas, Texas and 17 other locations · NCT05935358

• Understanding antibody changes in hemophilia A patients treated with emicizumab

  This study looks at how the immune system reacts to emicizumab treatment in people with severe hemophilia A by checking leftover samples from their regular doctor visits.

  Recruiting Goethe University · Frankfurt am Main, Hesse · NCT05802836

• Emicizumab treatment for severe Von Willebrand Disease and Hemophilia A

  This study is testing if a new injection called Emicizumab can help people with severe Von Willebrand Disease or both Von Willebrand Disease and Hemophilia A prevent serious bleeding better than current treatments.

  Recruiting at 12 sites Phase 1 Bleeding and Clotting Disorders Institute Peoria, Illinois · Orange, California and 11 other locations · NCT05500807

• Comparing Factor VIII and Emicizumab for Preventing Bleeding in Hemophilia A Patients Playing Sports

  This study tests whether Factor VIII or Emicizumab is better at preventing bleeding in boys aged 6 to 19 with Hemophilia A while they play sports.

  Recruiting at 10 sites Wayne State University · Little Rock, Arkansas and 9 other locations · NCT05022459

• Using Hemlibra to treat mild hemophilia A

  This study is testing if Hemlibra can safely help men with mild hemophilia A manage their condition and improve their joint health and quality of life.

  Recruiting Phase 4 Indiana Hemophilia &Thrombosis Center, Inc. · Indianapolis, Indiana · NCT04567511

Quick answers

How many clinical trials of Emicizumab are recruiting right now?

9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 31 countries. The most sites are in United States (8 trials), Germany (4 trials), France (3 trials), Italy (3 trials), Spain (3 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 4: 3, Phase 1: 2, Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →